Natco Pharma announced that the Board of Directors of the Company at its meeting held on 8 August 2018, inter alia, have recommended the interim dividend of Rs 1.5 per equity Share (i.e. 75%) , subject to the approval of the shareholders.
Natco Pharma standalone net profit rises 93.63% in the June 2018 quarter
09 - Aug - 2018 12:00 AM | 45 days ago
Net profit of Natco Pharma rose 93.63% to Rs 188.60 crore in the quarter ended June 2018 as against Rs 97.40 crore during the previous quarter ended June 2017. Sales rose 24.69% to Rs 515.70 crore in the quarter ended June 2018 as against Rs 413.60 crore during the previous quarter ended June 2017.
Natco Pharma consolidated net profit rises 93.28% in the June 2018 quarter
09 - Aug - 2018 12:00 AM | 45 days ago
Net profit of Natco Pharma rose 93.28% to Rs 181.10 crore in the quarter ended June 2018 as against Rs 93.70 crore during the previous quarter ended June 2017. Sales rose 25.81% to Rs 538.60 crore in the quarter ended June 2018 as against Rs 428.10 crore during the previous quarter ended June 2017.
